4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth

Contributed by: Business Wire

Logo

Images

Luc Boblet, CEO OF 4Moving Biotech (Photo: Business Wire)

Business Wire embedded0

Tags

Biotechnology

Health

Genetics

Pharmaceutical

Clinical Trials

4Moving Biotech

More Like This

(Graphic: Business Wire)

4Moving Biotech forms its Scientific Advisory Board of World-Renowned Knee Osteoarthritis Experts

(Photo: Business Wire)

4Moving Biotech Completes the Recruitment of Its Phase I Clinical Trial in Patients With Knee Osteoarthritis

(Graphic: Business Wire)

4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients

4P-Pharma welcomes Marina Vasiliou, Christian Bechon and Alain Sainsot as independent members of its board (Photo: Business Wire)

4P-Pharma Welcomes Marina Vasiliou, Christian Bechon, and Alain Sainsot as Independent Members of Its Board

EGLE Therapeutics Strengthens its Leadership Team with the Appointment of Pejvack Motlagh, MD, MSc, as Chief Medical Officer and its Board of Directors with Appointment of John Celebi, MBA, as Independent Board Member

Jérôme Vailland 4P-Pharma Chief Financial Officer (Photo: Business Wire)

Jérôme Vailland Joins 4P-Pharma as Chief Financial Officer

PR Newswire associated0

Telum Therapeutics appoints Dr. Subhendu Basu as CEO

PR Newswire associated0

Wheeler Bio Appoints Industry Veteran Patrick Lucy as Chief Executive Officer